Home Medicine Harmonisation of specialist training and continuing professional development in laboratory medicine: a long but necessary journey
Article Publicly Available

Harmonisation of specialist training and continuing professional development in laboratory medicine: a long but necessary journey

  • Graham H. Beastall EMAIL logo
Published/Copyright: November 4, 2014

Harmonisation has become a major topic in laboratory medicine over recent years. It is driven by the simple but important belief that reducing variability in an increasingly global healthcare environment will lead to more consistent and higher standards of practice, which, in turn, will lead to improved clinical outcomes and enhanced patient safety.

The standardisation of methods in laboratory medicine has been a core activity of the International Federation of Clinical Chemistry and Laboratory Medicine for many years [1]. More recently, it has been accepted that it is both possible and desirable to harmonise methods where formal standardisation may not be possible [2]. The clinical benefits of method standardisation and harmonisation are beginning to be realised [3, 4].

It has also been appreciated that harmonisation should extend well beyond laboratory methods. Accordingly, harmonisation initiatives have been undertaken in reference intervals, test names and laboratory practices [5]; in pre-analytical quality indicators [6]; and in steps towards medical laboratory accreditation [7]. There is a growing call for laboratory medicine specialists to embrace harmonisation across the complete scope of laboratory medicine practice [8, 9]. There have even been special issues of journals dedicated to harmonisation in laboratory medicine [10, 11]. Thus, there is growing acceptance of the proposal that harmonisation is part of the added value of laboratory medicine and that it is a professional responsibility [12].

Amidst this commendable activity and ‘call to arms’ one aspect of laboratory medicine has been largely overlooked. Can we assume that the specialists in laboratory medicine who are being urged to embrace harmonisation are operating from a level playing field of education, training and continuing professional development? Intuitively, we may expect the answer to be ‘no’ and this issue of the journal provides convincing and concerning evidence of wide diversity in specialist training [13] and continuing professional development [14] within countries of the European Union (EU). Such variability in the building blocks of our profession has implications not only for the free movement of professionals within the EU but also of our ability to harmonise our practices in the best interests of patients.

The publication from Oosterhuis and Zerah [13] contains the results of a wide ranging survey conducted among 28 countries within the EU. The findings reveal considerable variation between countries, including:

  1. The name of the specialty and the professionals who work in the specialty;

  2. The professional background of specialists; medical, scientist, pharmacist;

  3. The organisation and service delivery of sub-specialties of laboratory medicine;

  4. The length and content of specialist training and the assessment of that training;

  5. The professional responsibilities of individual specialists, especially in clinical areas;

  6. The requirement for registration and re-registration of professionals.

The survey did not assess the extent to which specialist training in the different countries embraces the more generic aspects of professionalism, such as good medical/scientific practice; leadership; or research, development and innovation. However, it seems likely that the pattern of variation will extend into these areas.

The results of the survey will come as no surprise to those of us working in the specialty. There is an issue about our identity with peers, users of the service, patients and the public. A high percentage of clinical decisions are influenced by the results that we produce [12] but our failure to present ourselves as a readily identifiable specialty within medicine means that our impact is poorly appreciated. The recent decision of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) to adopt the term ‘specialist in laboratory medicine’ is a welcome move to make the profession more recognisable [15].

The variation in specialty training exists despite the efforts of the European Union of Medical Specialists [Union Européene des Médecins Spécialistes (UEMS)] Section of Laboratory Medicine, Medical Biopathology and the EC4 European Register of Specialists in Laboratory Medicine, both of which have well established standards and curricula for specialist training in laboratory medicine [16, 17]. However, as the survey [13] reveals adherence to these standards and curricula is variable.

Continuing professional development (CPD) (also known as continuing medical education) is now undertaken by trained specialists in laboratory medicine in most European countries [13]. The publication by Martin and colleagues [14] looks in detail at the approaches to and measurement of CPD in four European countries. This study reveals marked variation in:

  1. The approaches to and requirements for CPD;

  2. The amount, content and assessment of CPD;

  3. The extent to which CPD encourages the specialist to reflect on their practice.

The authors point out that there is little evidence for the desired link between the completion of CPD and competence. Overall, the conclusion from the study is that European employers should understand that CPD, as currently practised, is variable.

The take away message from these two publications is that we are a long way from having a harmonised profession of specialists in laboratory medicine in Europe. The main driver for professional harmonisation in Europe has been two-fold: to establish high standards of training; and to encourage free movement of specialists across the EU. Medical doctors, including specialists in laboratory medicine, are subject to UEMS charters and European Commission (EC) directives, which allow automatic recognition of basic medical training and specialist doctor training [18]. Recently, the EC Directive on Recognition of Professional Qualifications (Directive 2005/36/EC) has been revised to allow harmonisation of some professions under ‘Common training frameworks’ [19]. EFLM is currently working to establish the ‘specialist in laboratory medicine’ as a harmonised profession for the primary scientist and pharmacist specialists in laboratory medicine. If this can be achieved then the separate harmonisation of medical specialists and non-medical specialists in laboratory medicine will be facilitated but the harmonisation between medical and non-medical specialists will remain to be addressed.

High standards of training and free movement of specialists across the EU are desirable and are a positive development for specialists within the profession. However, on their own, they are no guarantee of uniform high standards of practice. As the momentum to harmonise the professional practice of laboratory medicine grows it is likely that a barrier to implementation will be the variable understanding of the need for and expected outcomes of harmonisation, which in turn may be traced back to variations in specialty training.

Looking to the future it is perhaps convenient to consider three related areas for further work:

  1. More effort is required to reduce variability in the content of specialty training in laboratory medicine. This should occur for medical specialists, for non-medical specialists and, ideally, between medical and non-medical specialists. Individual countries have invested huge resources into specialty training, which has been tailored to meet their particular approach to service organisation and delivery. Therefore, full integration of specialty training in laboratory medicine is an unrealistic goal. The most practicable approach will be to further develop, and align, the standards and curricula that have already been produced by UEMS and EC4 and to present them as a framework. Individual specialty training schemes may then be ‘plugged into’ that framework to show areas of commonality and areas of difference, which individual specialty training schemes may care to address. UEMS and EFLM are the obvious organisations to lead this project.

  2. A common approach to clinical leadership training will help specialists in laboratory medicine to understand the clinical context of their work; the benefits of multidisciplinary team working; the move towards increasing patient focus; and the requirements for high levels of professionalism as defined in good medical/scientific practice. Harmonisation of practice will depend on strong clinical leadership from the profession. Clinical leadership training is still at an early stage in many countries and so the opportunity exists to establish standards and a common framework before national schemes become too entrenched. In an increasingly global community clinical leadership training may benefit from an international as well as a European initiative.

  3. The purpose of CPD needs to be clarified and, if possible, the approach to CPD should be harmonised. Attendance at conferences and reading scientific publications are valuable ways to gain new knowledge and keep up to date with scientific developments but on their own they do not improve the competence of the specialist or the clinical relevance of the service that they oversee. An international framework for CPD for specialists in laboratory medicine would seem to be a worthy, if challenging, objective.

Consideration of the second and third suggested areas of further work leads to an appreciation that they are not specific to laboratory medicine. Indeed, they apply to all specialties of medicine and across healthcare. There may be considerable merit in establishing what other specialties are doing and in encouraging a multi-professional approach to clinical leadership training and the future of CPD. In Europe leadership can be provided by UEMS and EFLM working together with their international partners and with other expert stakeholders.

As this editorial reveals the harmonisation of specialty training and CPD is complex and challenging. It is a journey that will be long and fraught with barriers. However, the public and patients have a right to expect uniform high standards of practice and care at European and international level. Therefore, the journey towards more harmonised specialty training, better clinical leadership and meaningful CPD is a necessary one.

Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Financial support: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Corresponding author: Dr. Graham H. Beastall, University of Glasgow, Mayfield, Birdston, Glasgow G66 1 RW, UK; and Past President, International Federation of Clinical Chemistry and Laboratory Medicine, Phone: +44 141 7761565, E-mail:

References

1. Gillery P, Young IS. Progress towards standardization: an IFCC Scientific Division Perspective. Clin Chem Lab Med 2013;51: 915–8.10.1515/cclm-2013-0081Search in Google Scholar PubMed

2. Miller WG, Myers GL, Gantzer ML, Kahn SE, Schönbrunner ER, Thienpont LM, et al. Roadmap for harmonization of clinical laboratory measurement procedures. Clin Chem 2011;57:1108–17.10.1373/clinchem.2011.164012Search in Google Scholar PubMed

3. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in US deaths from coronary disease 1980–2000. N Engl J Med 2007;356:2388–98.10.1056/NEJMsa053935Search in Google Scholar PubMed

4. Hoerger TJ, Wittenborn JS, Young W. A cost-benefit analysis of lipid standardization in the United States. Prev Chronic Dis 2011;8:A136.Search in Google Scholar

5. Berg J. The UK Pathology Harmony initiative: the foundation of a global model. Clin Chim Acta 2014;432:22–6.10.1016/j.cca.2013.10.019Search in Google Scholar PubMed

6. Plebani M, Astion ML, Barth JH, Chen W, de Oliveira Galoro CA, Escuer MI, et al. Harmonization of quality indicators in laboratory medicine. A preliminary consensus. Clin Chem Lab Med 2014;52:951–8.Search in Google Scholar

7. Huisman W. European medical laboratory accreditation. Present situation and steps to harmonisation. Clin Chem Lab Med 2012;50:1147–52.10.1515/cclm-2011-0586Search in Google Scholar PubMed

8. Plebani M. Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 2013;51:741–51.10.1515/cclm-2013-0075Search in Google Scholar PubMed

9. Aarsand AK, Sandberg S. How to achieve harmonisation of laboratory testing – the complete picture. Clin Chim Acta 2014;432:8–14.10.1016/j.cca.2013.12.005Search in Google Scholar PubMed

10. Tate JR, Johnson R, Legg M, editors. Harmonisation of laboratory testing. Clin Biochem Rev 2012;33:81–118.Search in Google Scholar

11. Tate JR, Johnson R, Barth JR, Panteghini M, editors. Harmonization of laboratory practice – a global activity. Clin Chim Acta 2014;432:1–166.10.1016/j.cca.2014.02.006Search in Google Scholar PubMed

12. Beastall GH. Adding value to laboratory medicine: a professional responsibility. Clin Chem Lab Med 2013;51:221–7.10.1515/cclm-2012-0630Search in Google Scholar PubMed

13. Oosterhuis WP, Zerah S. Laboratory medicine in the European Union. Clin Chem Lab Med 2015;53:5–14.Search in Google Scholar

14. Martin J, Gasljevic V, Šalec T, Horvath A, Borg C, Flegar-Meštrić Z, et al. Comparison of approaches and measurement of continuing professional development for specialists in laboratory medicine within four European countries. Clin Chem Lab Med 2015;53:35–44.10.1515/cclm-2014-0415Search in Google Scholar PubMed

15. Zerah S, McMurray J, Horvath AR. Our profession now has a European name: specialist in laboratory medicine. EFCC newsletter May 2011. Available from: http://www.efcclm.org/files/efcc/files/EFLM%20Newsletter%202011-05.pdf. Accessed 10 October, 2014.Search in Google Scholar

16. Recommended standards for training specialists in laboratory medicine/medical biopathology. Available from: www.uems-slm.org/uems/01-PDF/BB_2012May_Final.pdf. Accessed 10 October, 2014.Search in Google Scholar

17. McMurray J, Zerah S, Hallworth M, Schuff-Werner P, Haushofer A, Szekeres T, et al. The European register of specialists in clinical chemistry and laboratory medicine: guide to the register, version 3-2010. Clin Chem Lab Med 2010;48:999–1008.10.1515/CCLM.2010.223Search in Google Scholar PubMed

18. The EU single market. Doctors. Available from: www.ec.europa.eu/internal_market/qualifications/directive_in_practice/automatic_recognition/doctors/index_en.htm. Accessed 10 October, 2014.Search in Google Scholar

19. Directive 2013/55/EU of the European Parliament and of the Council of 20 November 2013; amending Directive 2005/36/EC on the recognition of professional qualifications and regulation (EU) No 1024/2012 on administrative cooperation through the internal market information system. Available from: www.eaeve.org/fileadmin/downloads/sop/DIR_2013_55_EU_amended_rpq.pdf. Accessed 10 October, 2014.Search in Google Scholar

Published Online: 2014-11-4
Published in Print: 2015-1-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Harmonisation of specialist training and continuing professional development in laboratory medicine: a long but necessary journey
  4. Reviews
  5. Laboratory medicine in the European Union
  6. Role of leptin in female reproduction
  7. Mini Review
  8. Interrelatedness between C-reactive protein and oxidized low-density lipoprotein
  9. General Clinical Chemistry and Laboratory Medicine
  10. Comparison of approaches and measurement of continuing professional development for specialists in laboratory medicine within four European countries
  11. Point-of-care urine albumin in general practice offices: effect of participation in an external quality assurance scheme
  12. Triple positive antiphospholipid antibody profile in outpatients with tests for lupus anticoagulants
  13. Effects of cigarette smoking on circulating leukocytes and plasma cytokines in monozygotic twins
  14. Proteolysis is a confounding factor in the interpretation of faecal calprotectin
  15. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients
  16. Cancer Diagnostics
  17. Quantification of adult T-cell leukemia/lymphoma cells using simple four-color flow cytometry
  18. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development
  19. Cardiovascular Diseases
  20. Increased serum homocitrulline concentrations are associated with the severity of coronary artery disease
  21. S100B concentrations increase perioperatively in jugular vein blood despite limited metabolic and inflammatory response to clinically uneventful carotid endarterectomy
  22. Long-term biological variability of galectin-3 after heart transplantation
  23. Diabetes
  24. Evaluation of a next generation direct whole blood enzymatic assay for hemoglobin A1c on the ARCHITECT c8000 chemistry system
  25. The 13C-glucose breath test is a valid non-invasive screening tool to identify metabolic syndrome in adolescents
  26. Comparison of a direct enzymatic assay and polyacrylamide tube gel electrophoresis for measurement of small, dense low-density lipoprotein cholesterol
  27. Letters to the Editor
  28. Comparison of Abbott Architect high-sensitivity troponin I in Rapid Serum Tubes and plasma
  29. Can EDTA, EDTA-fluoride, and buffered citrate tubes be used for measurement of HbA1c on the Bio-Rad D10?
  30. How to reduce EDTA contamination in laboratory specimens: a Tunisian experience
  31. Does mean platelet volume share any relationship with biochemical and hematological parameters?
  32. Association of retrospective markers of glycemia and the use of continuous glucose monitoring in white adults with type 2 diabetes mellitus – a preliminary report
  33. Operative performances and efficiency for infectious disease testing of two immunochemistry analyzers – Abbott ARCHITECT i2000SR and DiaSorin Liaison XL
Downloaded on 9.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-1005/html
Scroll to top button